Firms

BioAdvance Capital

BioAdvance Capital

bioadvance.com

BioAdvance Capital is an evergreen life sciences investor that provides early-stage capital and company-building support to businesses improving human health in the US Mid-Atlantic region. It focuses on seed and Series A companies headquartered along the New York-to-Washington corridor, investing in therapeutics, medical devices, digital health, diagnostics and research tools. Its initial investments typically range from USD500,000 to USD1.5 million, with capacity to invest up to USD5 million over a company’s development. Its portfolio includes neurological drug development, brain-injury assessment, cell and gene therapies and AI-enabled healthcare and drug discovery. Returns from portfolio exits support further investments through its evergreen model.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Adam GlasoferEntrepreneur-in-Residence
Barbara SchilbergAdviser, Former Chief Executive Officer and Board Member
David ShinPartner
Frank De MariaMarketing Communications Adviser
Gayle MineoOffice Management
Gregory HarrimanPartner
Jeff EdelsonEntrepreneur-in-Residence
Jen GilburgBoard Member
Jonathan EpsteinBoard Member
Lauren LenfestBoard Member
Marie LindnerEntrepreneur-in-Residence and Board Member
Marnie McCoyProgram Director
Michael LarkEntrepreneur-in-Residence
Philip P. GerbinoBoard Member
Rick JonesAdviser and Former Partner
Robert DriscollDirector of Finance
Roy M. RosenBoard Member
Shahram HejaziManaging Director, Chief Executive Officer and Board Member
Steven NichtbergerBoard Member

Co-investing

Investments